nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Decreased appetite—Bleomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Esmolol—Angiopathy—Etoposide—testicular cancer	0.00185	0.00185	CcSEcCtD
Esmolol—Confusional state—Ifosfamide—testicular cancer	0.00185	0.00185	CcSEcCtD
Esmolol—Abnormal vision—Doxorubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Pain—Bleomycin—testicular cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Oedema—Ifosfamide—testicular cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Chills—Etoposide—testicular cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Mental disability—Doxorubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Asthenia—Vinblastine—testicular cancer	0.00182	0.00182	CcSEcCtD
Esmolol—Cardiac failure congestive—Epirubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Esmolol—Nervous system disorder—Ifosfamide—testicular cancer	0.0018	0.0018	CcSEcCtD
Esmolol—Skin disorder—Ifosfamide—testicular cancer	0.00178	0.00178	CcSEcCtD
Esmolol—Hyperhidrosis—Ifosfamide—testicular cancer	0.00177	0.00177	CcSEcCtD
Esmolol—Feeling abnormal—Bleomycin—testicular cancer	0.00177	0.00177	CcSEcCtD
Esmolol—Thrombophlebitis—Doxorubicin—testicular cancer	0.00176	0.00176	CcSEcCtD
Esmolol—Vomiting—Chlorambucil—testicular cancer	0.00176	0.00176	CcSEcCtD
Esmolol—Anorexia—Ifosfamide—testicular cancer	0.00175	0.00175	CcSEcCtD
Esmolol—Decreased appetite—Dactinomycin—testicular cancer	0.00174	0.00174	CcSEcCtD
Esmolol—Dysgeusia—Etoposide—testicular cancer	0.00174	0.00174	CcSEcCtD
Esmolol—Dermatitis bullous—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Esmolol—Fatigue—Dactinomycin—testicular cancer	0.00172	0.00172	CcSEcCtD
Esmolol—Hypotension—Ifosfamide—testicular cancer	0.00171	0.00171	CcSEcCtD
Esmolol—Pain—Dactinomycin—testicular cancer	0.00171	0.00171	CcSEcCtD
Esmolol—Urticaria—Bleomycin—testicular cancer	0.0017	0.0017	CcSEcCtD
Esmolol—Body temperature increased—Bleomycin—testicular cancer	0.00169	0.00169	CcSEcCtD
Esmolol—Cardiac failure—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Esmolol—Irritability—Methotrexate—testicular cancer	0.00168	0.00168	CcSEcCtD
Esmolol—Dizziness—Vinblastine—testicular cancer	0.00168	0.00168	CcSEcCtD
Esmolol—Convulsion—Cisplatin—testicular cancer	0.00168	0.00168	CcSEcCtD
Esmolol—Feeling abnormal—Dactinomycin—testicular cancer	0.00165	0.00165	CcSEcCtD
Esmolol—Nausea—Chlorambucil—testicular cancer	0.00165	0.00165	CcSEcCtD
Esmolol—Paraesthesia—Ifosfamide—testicular cancer	0.00165	0.00165	CcSEcCtD
Esmolol—Anxiety—Cisplatin—testicular cancer	0.00164	0.00164	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00164	0.00164	CcSEcCtD
Esmolol—Dyspnoea—Ifosfamide—testicular cancer	0.00163	0.00163	CcSEcCtD
Esmolol—Somnolence—Ifosfamide—testicular cancer	0.00163	0.00163	CcSEcCtD
Esmolol—Vomiting—Vinblastine—testicular cancer	0.00161	0.00161	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Esmolol—Decreased appetite—Ifosfamide—testicular cancer	0.00159	0.00159	CcSEcCtD
Esmolol—Headache—Vinblastine—testicular cancer	0.00159	0.00159	CcSEcCtD
Esmolol—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00158	0.00158	CcSEcCtD
Esmolol—Body temperature increased—Dactinomycin—testicular cancer	0.00158	0.00158	CcSEcCtD
Esmolol—Fatigue—Ifosfamide—testicular cancer	0.00158	0.00158	CcSEcCtD
Esmolol—Oedema—Cisplatin—testicular cancer	0.00158	0.00158	CcSEcCtD
Esmolol—Cardiac arrest—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Esmolol—Pain—Ifosfamide—testicular cancer	0.00157	0.00157	CcSEcCtD
Esmolol—Constipation—Ifosfamide—testicular cancer	0.00157	0.00157	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Esmolol—Loss of consciousness—Etoposide—testicular cancer	0.00156	0.00156	CcSEcCtD
Esmolol—Nervous system disorder—Cisplatin—testicular cancer	0.00155	0.00155	CcSEcCtD
Esmolol—Asthenia—Bleomycin—testicular cancer	0.00154	0.00154	CcSEcCtD
Esmolol—Convulsion—Etoposide—testicular cancer	0.00154	0.00154	CcSEcCtD
Esmolol—Skin disorder—Cisplatin—testicular cancer	0.00153	0.00153	CcSEcCtD
Esmolol—Hyperhidrosis—Cisplatin—testicular cancer	0.00153	0.00153	CcSEcCtD
Esmolol—Pruritus—Bleomycin—testicular cancer	0.00152	0.00152	CcSEcCtD
Esmolol—Feeling abnormal—Ifosfamide—testicular cancer	0.00151	0.00151	CcSEcCtD
Esmolol—Chest pain—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Esmolol—Nausea—Vinblastine—testicular cancer	0.00151	0.00151	CcSEcCtD
Esmolol—Anorexia—Cisplatin—testicular cancer	0.00151	0.00151	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.0015	0.0015	CcSEcCtD
Esmolol—Hypotension—Cisplatin—testicular cancer	0.00148	0.00148	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Esmolol—Abdominal discomfort—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Esmolol—Confusional state—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Esmolol—Urticaria—Ifosfamide—testicular cancer	0.00146	0.00146	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Esmolol—Body temperature increased—Ifosfamide—testicular cancer	0.00145	0.00145	CcSEcCtD
Esmolol—Asthenia—Dactinomycin—testicular cancer	0.00143	0.00143	CcSEcCtD
Esmolol—Dysuria—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Esmolol—Paraesthesia—Cisplatin—testicular cancer	0.00142	0.00142	CcSEcCtD
Esmolol—Dyspnoea—Cisplatin—testicular cancer	0.00141	0.00141	CcSEcCtD
Esmolol—Skin disorder—Etoposide—testicular cancer	0.00141	0.00141	CcSEcCtD
Esmolol—Hyperhidrosis—Etoposide—testicular cancer	0.0014	0.0014	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Esmolol—Anorexia—Etoposide—testicular cancer	0.00138	0.00138	CcSEcCtD
Esmolol—Decreased appetite—Cisplatin—testicular cancer	0.00137	0.00137	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Esmolol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00136	0.00136	CcSEcCtD
Esmolol—Vomiting—Bleomycin—testicular cancer	0.00136	0.00136	CcSEcCtD
Esmolol—Drowsiness—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Esmolol—Hypotension—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Esmolol—Pain—Cisplatin—testicular cancer	0.00135	0.00135	CcSEcCtD
Esmolol—Dysuria—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Esmolol—Asthenia—Ifosfamide—testicular cancer	0.00131	0.00131	CcSEcCtD
Esmolol—Feeling abnormal—Cisplatin—testicular cancer	0.0013	0.0013	CcSEcCtD
Esmolol—Paraesthesia—Etoposide—testicular cancer	0.0013	0.0013	CcSEcCtD
Esmolol—Pruritus—Ifosfamide—testicular cancer	0.0013	0.0013	CcSEcCtD
Esmolol—Dyspnoea—Etoposide—testicular cancer	0.00129	0.00129	CcSEcCtD
Esmolol—Somnolence—Etoposide—testicular cancer	0.00129	0.00129	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Esmolol—Nausea—Bleomycin—testicular cancer	0.00127	0.00127	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Esmolol—Vomiting—Dactinomycin—testicular cancer	0.00127	0.00127	CcSEcCtD
Esmolol—Decreased appetite—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Esmolol—Gastrointestinal disorder—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Esmolol—Body temperature increased—Cisplatin—testicular cancer	0.00125	0.00125	CcSEcCtD
Esmolol—Fatigue—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Esmolol—Pain—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Esmolol—Constipation—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Esmolol—Dizziness—Ifosfamide—testicular cancer	0.00121	0.00121	CcSEcCtD
Esmolol—Pharyngitis—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Esmolol—Urinary tract disorder—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Esmolol—Urethral disorder—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Esmolol—Feeling abnormal—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Esmolol—Nausea—Dactinomycin—testicular cancer	0.00119	0.00119	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—testicular cancer	0.00118	0.00118	CcSEcCtD
Esmolol—Vomiting—Ifosfamide—testicular cancer	0.00117	0.00117	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Esmolol—Urticaria—Etoposide—testicular cancer	0.00115	0.00115	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Esmolol—Body temperature increased—Etoposide—testicular cancer	0.00114	0.00114	CcSEcCtD
Esmolol—Asthenia—Cisplatin—testicular cancer	0.00113	0.00113	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Esmolol—Chills—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Esmolol—Nausea—Ifosfamide—testicular cancer	0.00109	0.00109	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Esmolol—Erythema—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Esmolol—Flushing—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Esmolol—Asthenia—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Esmolol—Chills—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Esmolol—Pruritus—Etoposide—testicular cancer	0.00102	0.00102	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Esmolol—Vomiting—Cisplatin—testicular cancer	0.001	0.001	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Esmolol—Erythema—Epirubicin—testicular cancer	0.000994	0.000994	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Esmolol—Flushing—Doxorubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—testicular cancer	0.000973	0.000973	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Esmolol—Dizziness—Etoposide—testicular cancer	0.000957	0.000957	CcSEcCtD
Esmolol—Chills—Doxorubicin—testicular cancer	0.000948	0.000948	CcSEcCtD
Esmolol—Nausea—Cisplatin—testicular cancer	0.000938	0.000938	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—testicular cancer	0.000926	0.000926	CcSEcCtD
Esmolol—Convulsion—Methotrexate—testicular cancer	0.00092	0.00092	CcSEcCtD
Esmolol—Vomiting—Etoposide—testicular cancer	0.00092	0.00092	CcSEcCtD
Esmolol—Erythema—Doxorubicin—testicular cancer	0.00092	0.00092	CcSEcCtD
Esmolol—Agitation—Epirubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Esmolol—Headache—Etoposide—testicular cancer	0.000907	0.000907	CcSEcCtD
Esmolol—Chest pain—Methotrexate—testicular cancer	0.000904	0.000904	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—testicular cancer	0.000901	0.000901	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000898	0.000898	CcSEcCtD
Esmolol—Syncope—Epirubicin—testicular cancer	0.000891	0.000891	CcSEcCtD
Esmolol—Confusional state—Methotrexate—testicular cancer	0.000874	0.000874	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—testicular cancer	0.000874	0.000874	CcSEcCtD
Esmolol—Convulsion—Epirubicin—testicular cancer	0.000861	0.000861	CcSEcCtD
Esmolol—Nausea—Etoposide—testicular cancer	0.00086	0.00086	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—testicular cancer	0.00085	0.00085	CcSEcCtD
Esmolol—Chest pain—Epirubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Esmolol—Agitation—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Esmolol—Anxiety—Epirubicin—testicular cancer	0.000843	0.000843	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—testicular cancer	0.000842	0.000842	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00084	0.00084	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—testicular cancer	0.000838	0.000838	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—testicular cancer	0.000828	0.000828	CcSEcCtD
Esmolol—Anorexia—Methotrexate—testicular cancer	0.000826	0.000826	CcSEcCtD
Esmolol—Syncope—Doxorubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Esmolol—Confusional state—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Esmolol—Oedema—Epirubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Esmolol—Hypotension—Methotrexate—testicular cancer	0.00081	0.00081	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—testicular cancer	0.000808	0.000808	CcSEcCtD
Esmolol—Shock—Epirubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—testicular cancer	0.000796	0.000796	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—testicular cancer	0.000788	0.000788	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—testicular cancer	0.000784	0.000784	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—testicular cancer	0.00078	0.00078	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—testicular cancer	0.000778	0.000778	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Esmolol—Anorexia—Epirubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—testicular cancer	0.000773	0.000773	CcSEcCtD
Esmolol—Somnolence—Methotrexate—testicular cancer	0.000771	0.000771	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—testicular cancer	0.000763	0.000763	CcSEcCtD
Esmolol—Hypotension—Epirubicin—testicular cancer	0.000758	0.000758	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—testicular cancer	0.000754	0.000754	CcSEcCtD
Esmolol—Oedema—Doxorubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000748	0.000748	CcSEcCtD
Esmolol—Fatigue—Methotrexate—testicular cancer	0.000747	0.000747	CcSEcCtD
Esmolol—Pain—Methotrexate—testicular cancer	0.000741	0.000741	CcSEcCtD
Esmolol—Shock—Doxorubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—testicular cancer	0.000736	0.000736	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—testicular cancer	0.000729	0.000729	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—testicular cancer	0.000728	0.000728	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000726	0.000726	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—testicular cancer	0.000723	0.000723	CcSEcCtD
Esmolol—Somnolence—Epirubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—testicular cancer	0.000715	0.000715	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—testicular cancer	0.000714	0.000714	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—testicular cancer	0.000714	0.000714	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—testicular cancer	0.000701	0.000701	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Esmolol—Fatigue—Epirubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Esmolol—Pain—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Esmolol—Constipation—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Esmolol—Urticaria—Methotrexate—testicular cancer	0.000689	0.000689	CcSEcCtD
Esmolol—Body temperature increased—Methotrexate—testicular cancer	0.000685	0.000685	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—testicular cancer	0.000674	0.000674	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—testicular cancer	0.000668	0.000668	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—testicular cancer	0.000667	0.000667	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000648	0.000648	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Esmolol—Urticaria—Epirubicin—testicular cancer	0.000644	0.000644	CcSEcCtD
Esmolol—Pain—Doxorubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Esmolol—Constipation—Doxorubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—testicular cancer	0.000641	0.000641	CcSEcCtD
Esmolol—Asthenia—Methotrexate—testicular cancer	0.000622	0.000622	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Esmolol—Pruritus—Methotrexate—testicular cancer	0.000613	0.000613	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Esmolol—Asthenia—Epirubicin—testicular cancer	0.000582	0.000582	CcSEcCtD
Esmolol—Pruritus—Epirubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Esmolol—Dizziness—Methotrexate—testicular cancer	0.000573	0.000573	CcSEcCtD
Esmolol—Vomiting—Methotrexate—testicular cancer	0.000551	0.000551	CcSEcCtD
Esmolol—Headache—Methotrexate—testicular cancer	0.000543	0.000543	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—testicular cancer	0.000539	0.000539	CcSEcCtD
Esmolol—Dizziness—Epirubicin—testicular cancer	0.000536	0.000536	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Esmolol—Vomiting—Epirubicin—testicular cancer	0.000516	0.000516	CcSEcCtD
Esmolol—Nausea—Methotrexate—testicular cancer	0.000515	0.000515	CcSEcCtD
Esmolol—Headache—Epirubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—testicular cancer	0.000496	0.000496	CcSEcCtD
Esmolol—Nausea—Epirubicin—testicular cancer	0.000482	0.000482	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—testicular cancer	0.000477	0.000477	CcSEcCtD
Esmolol—Headache—Doxorubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Esmolol—Nausea—Doxorubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
